Penn Davis Mcfarland Inc Bristol Myers Squibb CO Transaction History

Penn Davis Mcfarland Inc

  • $882 Million
  • Q4 2024

A detailed history of Penn Davis Mcfarland Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Penn Davis Mcfarland Inc holds 357,829 shares of BMY stock, worth $20 Million. This represents 2.29% of its overall portfolio holdings.

Number of Shares
357,829
Previous 357,822 -0.0%
Holding current value
$20 Million
Previous $18.5 Million 9.29%
% of portfolio
2.29%
Previous 2.18%

Shares

30 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 16, 2025
BUY
$51.92 - $59.94 $363 - $419
7 Added 0.0%
357,829 $20.2 Million
Q3 2024

Oct 18, 2024
SELL
$39.66 - $51.75 $38,232 - $49,887
-964 Reduced 0.27%
357,822 $18.5 Million
Q2 2024

Jul 19, 2024
SELL
$40.25 - $52.99 $18,917 - $24,905
-470 Reduced 0.13%
358,786 $14.9 Million
Q1 2024

Apr 25, 2024
SELL
$47.98 - $54.4 $194,031 - $219,993
-4,044 Reduced 1.11%
359,256 $19.5 Million
Q4 2023

Jan 19, 2024
SELL
$48.48 - $57.85 $356,764 - $425,718
-7,359 Reduced 1.99%
363,300 $18.6 Million
Q3 2023

Oct 19, 2023
SELL
$57.89 - $64.73 $392,609 - $438,998
-6,782 Reduced 1.8%
370,659 $21.5 Million
Q2 2023

Jul 18, 2023
SELL
$63.71 - $70.74 $134,428 - $149,261
-2,110 Reduced 0.56%
377,441 $24.1 Million
Q1 2023

Apr 21, 2023
SELL
$65.71 - $74.53 $82,203 - $93,237
-1,251 Reduced 0.33%
379,551 $26.3 Million
Q4 2022

Jan 24, 2023
SELL
$68.48 - $81.09 $515,312 - $610,202
-7,525 Reduced 1.94%
380,802 $27.4 Million
Q3 2022

Oct 21, 2022
SELL
$0.13 - $76.84 $26 - $15,675
-204 Reduced 0.05%
388,327 $27.6 Million
Q2 2022

Jul 15, 2022
SELL
$72.62 - $79.98 $1.16 Million - $1.28 Million
-15,943 Reduced 3.94%
388,531 $29.9 Million
Q1 2022

Apr 27, 2022
SELL
$61.48 - $73.72 $700,564 - $840,039
-11,395 Reduced 2.74%
404,474 $29.5 Million
Q4 2021

Jan 20, 2022
BUY
$53.63 - $62.52 $97,177 - $113,286
1,812 Added 0.44%
415,869 $25.9 Million
Q3 2021

Oct 21, 2021
SELL
$59.17 - $69.31 $145,084 - $169,948
-2,452 Reduced 0.59%
414,057 $24.5 Million
Q2 2021

Jul 19, 2021
BUY
$61.91 - $67.42 $548,708 - $597,543
8,863 Added 2.17%
416,509 $27.8 Million
Q1 2021

Apr 21, 2021
BUY
$59.34 - $66.74 $40,469 - $45,516
682 Added 0.17%
407,646 $25.7 Million
Q4 2020

Jan 22, 2021
BUY
$57.74 - $65.43 $485,362 - $550,004
8,406 Added 2.11%
406,964 $25.2 Million
Q3 2020

Oct 28, 2020
BUY
$57.43 - $63.64 $5,857 - $6,491
102 Added 0.03%
398,558 $24 Million
Q2 2020

Jul 29, 2020
SELL
$54.82 - $64.09 $79,982 - $93,507
-1,459 Reduced 0.36%
398,456 $23.4 Million
Q1 2020

Apr 20, 2020
SELL
$46.4 - $67.43 $808,798 - $1.18 Million
-17,431 Reduced 4.18%
399,915 $22.3 Million
Q4 2019

Jan 17, 2020
BUY
$49.21 - $64.19 $9.93 Million - $12.9 Million
201,695 Added 93.53%
417,346 $26.8 Million
Q3 2019

Oct 25, 2019
BUY
$42.77 - $50.71 $97,430 - $115,517
2,278 Added 1.07%
215,651 $10.9 Million
Q2 2019

Jul 16, 2019
BUY
$44.62 - $49.34 $2.09 Million - $2.31 Million
46,903 Added 28.18%
213,373 $9.68 Million
Q1 2019

Apr 25, 2019
BUY
$45.12 - $53.8 $727,830 - $867,847
16,131 Added 10.73%
166,470 $7.94 Million
Q4 2018

Jan 18, 2019
BUY
$48.76 - $63.23 $770,798 - $999,539
15,808 Added 11.75%
150,339 $7.82 Million
Q3 2018

Oct 24, 2018
SELL
$55.19 - $62.25 $98,017 - $110,556
-1,776 Reduced 1.3%
134,531 $8.35 Million
Q2 2018

Jul 20, 2018
BUY
$50.53 - $62.98 $80,696 - $100,579
1,597 Added 1.19%
136,307 $7.54 Million
Q1 2018

Apr 26, 2018
SELL
$59.92 - $68.98 $37,270 - $42,905
-622 Reduced 0.46%
134,710 $8.52 Million
Q4 2017

Jan 18, 2018
SELL
$59.94 - $65.35 $33,985 - $37,053
-567 Reduced 0.42%
135,332 $8.29 Million
Q3 2017

Oct 19, 2017
BUY
$55.23 - $63.74 $7.51 Million - $8.66 Million
135,899
135,899 $8.66 Million

Others Institutions Holding BMY

# of Institutions
2,751
Shares Held
1.57B
Call Options Held
28M
Put Options Held
28.7M
View Full List

About BRISTOL MYERS SQUIBB CO

BMY Quotes by TradingView
  • Ticker BMY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,126,160,000
  • Market Cap $119B
  • Description
  • Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...
More about BMY
Track This Portfolio

Track Penn Davis Mcfarland Inc Portfolio

Follow Penn Davis Mcfarland Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Penn Davis Mcfarland Inc, based on Form 13F filings with the SEC.

News

Stay updated on Penn Davis Mcfarland Inc with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email